Zoetis Inc. (NYSE:ZTS) Shares Purchased by Chapman Investment Management LLC

Chapman Investment Management LLC raised its holdings in Zoetis Inc. (NYSE:ZTS) by 1.1% during the third quarter, Holdings Channel reports. The institutional investor owned 21,210 shares of the company’s stock after buying an additional 235 shares during the period. Zoetis makes up about 3.0% of Chapman Investment Management LLC’s holdings, making the stock its 13th largest position. Chapman Investment Management LLC’s holdings in Zoetis were worth $4,144,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Quarry LP raised its position in Zoetis by 273.2% in the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after purchasing an additional 153 shares during the last quarter. Fortitude Family Office LLC grew its holdings in shares of Zoetis by 1,387.5% during the third quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock worth $46,000 after buying an additional 222 shares during the last quarter. LRI Investments LLC acquired a new position in Zoetis in the 1st quarter valued at about $43,000. Central Valley Advisors LLC purchased a new stake in Zoetis during the 2nd quarter valued at approximately $49,000. Finally, Future Financial Wealth Managment LLC acquired a new stake in Zoetis during the 3rd quarter worth approximately $59,000. 92.80% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently commented on ZTS shares. Stifel Nicolaus raised their target price on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research note on Wednesday, September 18th. BTIG Research lifted their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Argus raised Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler lifted their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Finally, JPMorgan Chase & Co. increased their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $221.44.

Zoetis Stock Performance

Shares of ZTS stock opened at $181.95 on Friday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The firm has a market capitalization of $82.43 billion, a price-to-earnings ratio of 35.61, a price-to-earnings-growth ratio of 2.78 and a beta of 0.90. The company has a 50 day moving average price of $188.97 and a 200 day moving average price of $178.51. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The firm had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.31 billion. During the same quarter in the prior year, the company earned $1.41 EPS. The company’s revenue was up 8.3% on a year-over-year basis. Sell-side analysts anticipate that Zoetis Inc. will post 5.83 EPS for the current year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be paid a $0.432 dividend. The ex-dividend date is Thursday, October 31st. This represents a $1.73 annualized dividend and a dividend yield of 0.95%. Zoetis’s dividend payout ratio (DPR) is presently 33.66%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.